-
Expertise: Artemid Senior LoansDate of investment: 2026Nature of the deal: Change of ControlCountry: FranceArlettiehttps://www.arlettie.com/gb/enFounded in 1998, Arlettie is an international inventory management specialist for luxury brands, organising exclusive private sales that enable brands to address excess inventory while preserving exclusivity, confidentiality and brand equity. Through its platform, combining physical showrooms and digital events, Arlettie has established itself as a leading partner to luxury brands across Europe and the United States.
-
Expertise: Artemid Senior LoansDate of investment: 2026Nature of the deal: Primary LBOCountry: GermanyPflegiahttps://www.pflegia.de/Founded in 2019 in Germany, Pflegia has established itself as the leading specialist platform for the recruitment of healthcare professionals. Through its innovative reverse-recruitment model, the company enables candidates to choose from several employers, while helping healthcare providers address their growing need for qualified staff.
-
Expertise: Private DebtDate of investment: 2026Nature of the deal: Secondary LBOCountry: FranceBarkenehttps://barkene.fr/Founded in 2018, Barkene a leading multi-specialist provider of mission-critical technical services in France, operating across electronic security, fire safety, automatic doors and remote monitoring.
-
Expertise: Private DebtDate of investment: 2026Nature of the deal: RefinancingCountry: FranceGO! Formationshttps://goformations.com/Go! Formations, founded in 2004, is a French training group that provides HSE regulatory training, apprenticeship programs, and business training to a diverse client base through its network of training centers.
-
Expertise: Flex EquityDate of investment: 2026Nature of the deal: Minority InvestmentCountry: FranceRespirehttps://respire.fr/Founded in 2018, Respire embodies a next-generation of pharmacy-based dermocosmetics players, with products built on proven long-term efficacy, clean and sensorial formulations, and short, limited and affordable ranges at affordable prices.
-
Expertise: Private DebtDate of investment: 2026Nature of the deal: Primary LBOCountry: SpainEvidenzehttps://evidenze.com/Evidenze Group is a full-service CRO supporting pharmaceutical, biotech and healthcare clients, from early-stage clinical trials through to product commercialisation. Evidenze operates across three core business lines: Clinical Research Services, Scientific Services and Digital Health Services.
Our investments
Our investments